SAI SREYAS PHARMACEUTICALS PRIVATE LIMITED

Overview

SAI SREYAS PHARMACEUTICALS PRIVATE LIMITED is an innovative pharmaceutical company based in India, dedicated to developing and manufacturing a wide range of high-quality medications. The company focuses on providing affordable healthcare solutions across various therapeutic areas.

Therapeutic areas

API / Drug Master Files

SAI SREYAS PHARMACEUTICALS PRIVATE LIMITED holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• EMPAGLIFLOZIN INTERMEDIATE- (2R,3R,4R,5S,6S)-2-(ACETOXYMETHYL)-6-(4-CHLORO-3-(4-(((S)-TETRAHYDROFURAN-3-YL)OXY)BENZYL)PHENYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIYL TRIACETATE (EMP-5) (CAS NO.- 915095-99-7)Active2026-01-24

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SAI SREYAS PHARMACEUTICALS PRIVATE LIMITED in our records. PharmaTek screens the full directory against live FDA enforcement data.